Prescription Drugs

New research, to be published in the Journal of Clinical Psychiatry, finds that men who developed persistent sexual side effects while on finasteride (Propecia), a drug commonly used for male pattern hair loss, have a high prevalence of depressive symptoms and suicidal thoughts.

A picture tells a thousand words, so they say. Today, ANH-Intl releases hard data in graphical format, from official sources, showing that food supplements are the safest substances to which we are commonly exposed – while being the target of increasingly restrictive European legislation aimed at ‘protecting consumers’.

Results from a study conducted at Georgia State University suggest that a "fight" between bacteria normally living in the intestines and the immune system, kicked off by another type of bacteria, may be linked to two types of chronic disease.

Consumer Reports (CR) claims to be a trustworthy, unbiased source of information. But where nutritional supplements are concerned, they either think that scare-mongering sells, or they have a deep bias, or both. The lead article in their September issue identifies ten supposed “hazards” of supplements—among them that “supplements are not risk-free.”

If supplements caused such adverse events, they would be banned immediately! Fortunately there are excellent supplement alternatives to these drugs. Two popular drugs—Proscar, used to treat an enlarged prostate, and Propecia, which is used to treat male pattern baldness—will now have new warnings from FDA on their labels for causing very undesirable sexual side effects even after you’ve stopped taking the drug!

The Food and Drug Administration cleared the drug, mirabegron, to treat the need to frequently or involuntarily urinate, the agency said today in a statement. The drug enhances bladder storage without affecting patients’ ability to urinate like others on the market. Tokyo-based Astellas will market the treatment as Myrbetriq, the FDA said.

Azithromycin (marketed as Zithromax) is most often prescribed to treat bronchitis, sinusitis, pneumonia, middle ear infections, and even certain sexually transmitted diseases. It can produce skin rashes, itching, swelling, difficulty breathing or swallowing, and rapid, pounding, or irregular heartbeats.

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

It is increasingly recognized that chronic psychotropic drug treatment may lead to structural remodeling of the brain. Indeed, clinical studies in humans present an intriguing picture: antipsychotics, used for the treatment of schizophrenia and psychosis, may contribute to cortical gray matter loss in patients, whereas lithium, used for the treatment of bipolar disorder and mania, may preserve gray matter in patients.

It is well known that drug-related morbidity is common among hospitalized patients, and is to some extent preventable, but less is known about drug-related morbidity outside hospitals. Two new studies conducted at the Nordic School of Public Health NHV, show that healthcare professionals perceive drug-related morbidity to affect half of all patients attending healthcare.

In contrasting China and America, pundits often cite our free and independent media as one of our greatest strengths, together with the tremendous importance which our society places upon individual American lives. For us, a single wrongful death can sometimes provoke weeks of massive media coverage and galvanize the nation into corrective action, while life remains cheap in China, a far poorer land of over a billion people, ruled by a ruthless Communist Party eager to bury its mistakes. But an examination of two of the greatest public-health scandals of the last few years casts serious doubt on this widespread belief.

The DEA is enabling—even encouraging—a generation of opiate addicts, while the FDA tries to quash safe and helpful supplements like DHEA. Goodness, the legal drug-makers have been busy! This week the Associated Press revealed that in 2010, US pharmacies dispensed the equivalent of 69 tons of pure oxycodone (used as ingredient in OxyContin, Percocet, and Percodan) and 42 tons of pure hydrocodone (used in Vicodin, Norco, and Lortab). That’s enough to give forty 5-milligram Percocets and twenty-four 5-milligram Vicodins to every single person in the United States.